Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.
3.

The effect of diltiazem on mortality and reinfarction after myocardial infarction.

Multicenter Diltiazem Postinfarction Trial Research Group.

N Engl J Med. 1988 Aug 18;319(7):385-92.

PMID:
2899840
4.

Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity.

Olsson G, Rehnqvist N, Sjögren A, Erhardt L, Lundman T.

J Am Coll Cardiol. 1985 Jun;5(6):1428-37.

5.

Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. The Multicenter Diltiazem Post-Infarction Trial Research Group.

Boden WE, Krone RJ, Kleiger RE, Oakes D, Greenberg H, Dwyer EJ Jr, Miller JP, Abrams J, Coromilas J, Goldstein R, et al.

Am J Cardiol. 1991 Feb 15;67(5):335-42.

PMID:
1994656
6.

Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial. Incomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT)

Boden WE, van Gilst WH, Scheldewaert RG, Starkey IR, Carlier MF, Julian DG, Whitehead A, Bertrand ME, Col JJ, Pedersen OL, Lie KI, Santoni JP, Fox KM.

Lancet. 2000 May 20;355(9217):1751-6.

PMID:
10832825
7.
9.
11.

Effects of diltiazem on recurrent myocardial infarction in patients with non-Q wave myocardial infarction.

Wong SC, Greenberg H, Hager WD, Dwyer EM Jr.

J Am Coll Cardiol. 1992 Jun;19(7):1421-5.

12.

Intravenous diltiazem in acute myocardial infarction. Diltiazem as adjunctive therapy to activase (DATA) trial.

Théroux P, Grégoire J, Chin C, Pelletier G, de Guise P, Juneau M.

J Am Coll Cardiol. 1998 Sep;32(3):620-8.

13.

Age-related prognosis after acute myocardial infarction (the Multicenter Diltiazem Postinfarction Trial).

Marcus FI, Friday K, McCans J, Moon T, Hahn E, Cobb L, Edwards J, Kuller L.

Am J Cardiol. 1990 Mar 1;65(9):559-66.

PMID:
2178380
14.

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.

Gibson RS, Boden WE, Theroux P, Strauss HD, Pratt CM, Gheorghiade M, Capone RJ, Crawford MH, Schlant RC, Kleiger RE, et al.

N Engl J Med. 1986 Aug 14;315(7):423-9.

PMID:
3526151
15.

Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.

Ishikawa K, Nakai S, Takenaka T, Kanamasa K, Hama J, Ogawa I, Yamamoto T, Oyaizu M, Kimura A, Yamamoto K, Yabushita H, Katori R.

Circulation. 1997 May 20;95(10):2368-73.

17.

Prevention of reinfarction subsequent to non-Q-wave infarction.

Roberts R, Gibson RS.

J Cardiovasc Pharmacol. 1989;13 Suppl 1:S36-46.

PMID:
2468975
19.

Calcium antagonists and myocardial infarction.

Hansen JF.

Cardiovasc Drugs Ther. 1991 Aug;5(4):665-70. Review.

PMID:
1888690
20.

Effect of diltiazem on cardiac rate and rhythm after myocardial infarction. Multicenter Diltiazem Postinfarction Trial Investigators.

Bigger JT Jr, Coromilas J, Rolnitzky LM, Fleiss JL, Kleiger RE.

Am J Cardiol. 1990 Mar 1;65(9):539-46.

PMID:
2178379

Supplemental Content

Support Center